Skip to main content

8-K/A

Nve Corp /New/ (NVEC)

8-K/A 2025-02-13 For: 2006-01-01
View Original
Added on April 07, 2026

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C.  20549

FORM 8-K/A

(Amendment No. 10)

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  January 1, 2006

Picture NVE Corp oration (Exact name of registrant as specified in its charter)

Minnesota 000-12196 41-1424202
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
11409 Valley View Road , Eden Prairie , Minnesota 55344
--- ---
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (952) 829-9217

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value NVEC The NASDAQ Stock Market, LLC

Explanatory Note

This Amendment No. 10 to Form 8-K is being filed to disclose Amendment No. 11 to our Supplier Partnering Agreement dated January 3, 2006 by and between Pacesetter, Inc., now a subsidiary of Abbott Laboratories (“Abbott”), and us, as amended by Amendment No. 1 to the Agreement dated September 6, 2007, Amendment No. 2 dated December 15, 2009, Amendment No. 3 dated September 13, 2010, Amendment No. 4 dated February 1, 2011, Amendment No. 5 dated April 20, 2016, Amendment No. 6 dated December 18, 2020, Amendment No. 7 dated April 30, 2021, Amendment No. 8 dated February 1, 2022, Amendment No. 9 dated January 20, 2023, and Amendment No. 10 received on January 2, 2024. Amendment Nos. 1, 2, 3, 6, 7, 9, and 10 were superseded by subsequent amendments.

Item 1.01. Entry into a Material Definitive Agreement.

General Information

We supply products to Abbott under the Supplier Partnering Agreement as amended.

Description of the Terms and Conditions of the Amendment

On February 10, 2025, Amendment No. 11 to the Supplier Partnering Agreement was executed, extending the Agreement term through December 31, 2025 and increases pricing for 2025. The Amendment is filed as Exhibit 10.6 to this Current Report on Form 8-K/A.

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date  February 13, 2025 NVE CORPORATION<br>(Registrant)<br><br><br>/s/ DANIEL A. BAKER<br>Daniel A. Baker<br>President & Chief Executive Officer

3


INDEX TO EXHIBITS

Exhibit # Description
10.1 Indemnification Agreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporated by reference to the Form 8-K filed September 27, 2005).
10.2+ Supplier Partnering Agreement by and between St. Jude and the company (incorporated by reference to the Form 8-K filed January 4, 2006).
10.3 Amendment No. 4 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed February 7, 2011).
10.4 Amendment No. 5 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed April 21, 2016).
10.5* Amendment No. 8 to Supplier Partnering Agreement between Abbott and the company (incorporated by reference to the Form 8-K/A filed February 2, 2022).
10.6* Amendment No. 11 to Supplier Partnering Agreement between Abbott and the company (filed with this Current Report on Form 8-K/A).
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

+Confidential portions of this exhibit were deleted and filed separately with the SEC under a request for confidential treatment pursuant to Rule 24b-2 or Rule 406.

*Certain confidential portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause us competitive harm if publicly disclosed. We agree to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission on its request.

4

Amendment to Supplier Partnering Agreement

AMENDMENT NO. 11

TO

SUPPLIER PARTNERING AGREEMENT

THIS AMENDMENT TO SUPPLIER PARTNERING AGREEMENT (this “Amendment”), dated as of December 17, 2024, (the “Amendment Effective Date”) is made and entered into by and between Pacesetter, Inc., with offices at 15900 Valley View Court, Sylmar, California, 91342 (“Buyer”), and NVE Corporation**,** with a principal place of business at 11409 Valley View Rd, Eden Prairie, Minnesota, 55344-3617 (“Seller”).

RECITALS

**A.**Buyer and Seller are parties to that certain SUPPLIER PARTNERING AGREEMENT with an effective date of January 1, 2006; Amendment No. 1 with an effective date of September 6, 2007; Amendment No. 2 with an effective date of December 15, 2009; Amendment No. 3 with an effective date of September 13, 2010; Amendment No. 4 with an effective date of February 1, 2011; Amendment No. 5 with an effective date of April 20, 2016; Amendment No. 6 with an effective date of December 16, 2020; Amendment No. 7 with an effective date of April 12, 2021;Amendment No. 8 with an effective date of November 10, 2021; Amendment No. 9 with an effective date of December 5, 2022; and Amendment No. 10 with an effective date of December 5, 2023 (collectively the “Agreement”).

B.Buyer and Seller now wish to amend the terms of Agreement as set forth in this Amendment.

NOW, THEREFORE, Buyer and Seller agree to amend the Agreement as follows:

  1. A new Section 10.9 is hereby added to the Agreement as follows:

10.9 Trade Controls.  Seller hereby represents and warrants, that Seller, its affiliates, agents, subcontractors, and employees performing services relating to this Agreement: (a) shall comply with applicable Trade Controls; (b) are not Sanctioned Persons; and (c) will not supply any Product or Sub-Component, in whole or in part, that directly or indirectly (i) has been produced, manufactured, extracted, or processed in a Sanctioned Area or (ii) has been procured from a Sanctioned Person. Seller shall impose the requirements in (a), (b), and (c) on all sub-suppliers of any Sub-Component and shall use commercially reasonable efforts to request that its sub-suppliers in turn impose such requirements on their upstream suppliers. Seller agrees to reasonably cooperate with Abbott to maintain compliance with applicable Trade Controls.  The following defined terms shall apply to this Section 12.5: “Sub-Component” means a tangible part or element of a Product, including, by way of example, and not limitation, raw materials, packaging, or semi-assembled components that are used to produce a finished Product.  “Product” means any product that is purchased under the Agreement, as may be set forth and/or further defined in an Exhibit to this Agreement, or in a Purchase Order.  “Sanctioned Area” means, at any time, a country or territory that is itself the target of comprehensive Sanctions (as of the date of this Agreement, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, the so-called Donetsk People’s Republic, and the so-called Luhansk People’s Republic, and as may be updated from time to time by Office of Foreign Assets Control of the U.S. Department of the Treasury).  “Sanctioned Person” means (a) any person listed in a Trade Controls-related list of designated persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, the European Union, any Member State of the European Union, or the United Kingdom, (b) any person operating, organized or resident in a Sanctioned Area, or (c) any person owned or controlled by, or acting for or on behalf of, any such person described in clauses (a) or (b). “Trade Controls” means economic and financial sanctions, trade embargoes, and import and export control Laws of the United States, the United Nations, the European Union, the United Kingdom or any other relevant authority unless in conflict with Laws of the United States.


9025.3 – NVE Corporation - Supply (Direct) Amended  Page 1 of 2


  1. Section 1, Term of Agreement, is hereby deleted and replaced with the following:

1.Term of Agreement.  This Agreement begins on January 1,2006 and will remain in force through December 31, 2025, unless terminated earlier.

  1. Attachment 1 is hereby amended to reflect a 2025 price of the following:

Part Number 1071000-001 increase from current price of $** to $**; Part Number 100101124 increase from current price of $** to $** and Part Number 100127071 increase from current price of $** to $**. These increases are effective with all shipments made after December 31, 2024.

  1. If any provisions of this Amendment and the Agreement conflict, the provisions of this Amendment shall prevail.  Except as specifically amended herein, all terms and conditions of the Agreement shall remain in full force and effect.

  2. Each party represents that it has authority to enter into this Amendment.  This Amendment may be executed in counterparts, each of which for all purposes shall be deemed an original, and all of which constitute, collectively, one agreement.  Facsimile or electronically transmitted signatures shall be deemed effective as originals.

The parties have caused this Amendment to be signed by their duly authorized representatives, effective as of the Amendment Effective Date.

Pacesetter, Inc.<br><br><br><br><br><br><br><br><br>By: /s/ Jonathan Harrington<br><br><br><br><br><br>Name: Jonathan Harrington<br><br><br><br><br><br>Title: DVP OPERATIONS+SUPPLY CHAIN<br><br><br><br><br><br>Date: 10 Feb 2025 NVE Corporation<br><br><br><br><br><br><br><br><br>By: /s/ Daniel A. Baker<br><br><br><br><br><br>Name: Daniel A. Baker<br><br><br><br><br><br>Title: President & CEO<br><br><br><br><br><br>Date: 1/27/25

9025.3 – NVE Corporation - Supply (Direct) Amended  Page 2 of 2